首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
【24h】

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

机译:在增强由MF59辅助大流行前疫苗引发的长寿命人记忆B细胞后,广泛交叉反应的抗体快速上升

获取原文
获取原文并翻译 | 示例
       

摘要

Proactive priming before the next pandemic could induce immune memory responses to novel influenza antigens. In an open-label study, we analyzed B cell memory and antibody responses of 54 adults who received 2 7.5-μg doses of MF59-adjuvanted A/Vietnam/ 1194/2004 clade 1 (H5N1) vaccine. Twenty-four subjects had been previously primed with MF59-adjuvanted or plain clade 0-like A/duck/Singapore/1997 (H5N3) vaccine during 1999-2001. The prevaccination frequency of circulating memory B cells reactive to A/Vietnam/1194/2004 was low in both primed and unprimed individuals. However, at day 21 after boosting, MF59-adjuvanted primed subjects displayed a higher frequency of H5N1-specific memory B cells than plain-primed or unprimed subjects. The immune memory was rapidly mobilized by a single vaccine administration and resulted in high titers of neutralizing antibodies to antigenically diverse clade 0,1, and 2 H5N1 viruses already at day 7. In general, postvaccination antibody titers were significantly higher in primed subjects than in unprimed subjects. Subjects primed with MF59-adjuvanted vaccine responded significantly better than those primed with plain vaccine, most notably in early induction and duration of cross-reacting antibody responses. After 6 months, high titers of cross-reactive antibody remained detectable among MF59-primed subjects. We conclude that distant priming with clade 0-like H5N3 induces a pool of cross-reactive memory B cells that can be boosted rapidly years afterward by a mismatched MF59-adjuvanted vaccine to generate high titers of cross-reactive neutralizing antibodies rapidly. These results suggest that pre-pandemic vaccination strategies should be considered.
机译:下一次大流行之前的主动引发可能诱导对新型流感抗原的免疫记忆反应。在一项开放标签研究中,我们分析了接受2份7.5微克剂量的MF59佐剂的A /越南/ 1194/2004进化枝1(H5N1)疫苗的54位成年人的B细胞记忆力和抗体应答。在1999-2001年期间,已有24名受试者接受了MF59佐剂或普通进化枝0样A /鸭/新加坡/ 1997(H5N3)疫苗的接种。在初免和未初免个体中,对A /越南/ 1194/2004有反应的循环记忆B细胞的预疫苗接种频率均较低。然而,在加强免疫后的第21天,MF59佐剂的初免对象显示的H5N1特异性记忆B细胞的频率高于普通或未初免的对象。免疫记忆通过单次疫苗接种迅速动员,并导致在第7天已经获得了高滴度的针对抗原多样的进化枝0,1和2 H5N1病毒的中和抗体。通常,初免接种疫苗的受试者的疫苗接种后抗体滴度显着高于中和。没有准备好的主题。接种MF59佐剂疫苗的受试者的反应显着优于普通疫苗,尤其是早期诱导和交叉反应抗体应答的持续时间。 6个月后,在MF59引发的受试者中仍可检测到高滴度的交叉反应抗体。我们得出的结论是,使用进化枝0样H5N3进行的远距离引物诱导了交叉反应性记忆B细胞池,这些细胞可在几年后通过错配的MF59佐剂疫苗迅速增强,从而迅速产生高滴度的交叉反应中和抗体。这些结果表明,应考虑大流行前的疫苗接种策略。

著录项

  • 来源
  • 作者单位

    Translational Medicine, Novartis Vaccines, Siena, Italy 53100;

    Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;

    Health Protection Agency, Colindale, London NW9 5HT, United Kingdom;

    Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;

    Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;

    Translational Medicine, Novartis Vaccines, Siena, Italy 53100;

    Translational Medicine, Novartis Vaccines, Siena, Italy 53100;

    Translational Medicine, Novartis Vaccines, Siena, Italy 53100;

    University of Siena, 53100 Siena, Italy;

    Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;

    Translational Medicine, Novartis Vaccines, Siena, Italy 53100;

    Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;

    Regulatory Affairs and Statistics, Novartis Vaccines, 35041 Marburg, Germany;

    University of Siena, 53100 Siena, Italy;

    Health Protection Agency, Colindale, London NW9 5HT, United Kingdom;

    Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333;

    Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;

    Department of Inflammation, Infection and Immunity, University of Leicester, Leicester LE1 9HN, United Kingdom;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:41:59

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号